Practice
Open Access
Persistent myopericarditis after heterologous SARS-CoV-2 mRNA vaccination
Kai Yi Wu, Craig R. Butler, Sheri Koshman, Gavin Y. Oudit and D. Ian Paterson
CMAJ April 24, 2023 195 (16) E584-E587; DOI: https://doi.org/10.1503/cmaj.221510
Kai Yi Wu
Mazankowski Alberta Heart Institute (Wu, Butler, Koshman, Oudit), Division of Cardiology, University of Alberta, Edmonton, Alta.; University of Ottawa Heart Institute (Paterson), Division of Cardiology, University of Ottawa, Ottawa, Ont.
MDCraig R. Butler
Mazankowski Alberta Heart Institute (Wu, Butler, Koshman, Oudit), Division of Cardiology, University of Alberta, Edmonton, Alta.; University of Ottawa Heart Institute (Paterson), Division of Cardiology, University of Ottawa, Ottawa, Ont.
MD MScSheri Koshman
Mazankowski Alberta Heart Institute (Wu, Butler, Koshman, Oudit), Division of Cardiology, University of Alberta, Edmonton, Alta.; University of Ottawa Heart Institute (Paterson), Division of Cardiology, University of Ottawa, Ottawa, Ont.
BScPharm PharmDGavin Y. Oudit
Mazankowski Alberta Heart Institute (Wu, Butler, Koshman, Oudit), Division of Cardiology, University of Alberta, Edmonton, Alta.; University of Ottawa Heart Institute (Paterson), Division of Cardiology, University of Ottawa, Ottawa, Ont.
MD PhDD. Ian Paterson
Mazankowski Alberta Heart Institute (Wu, Butler, Koshman, Oudit), Division of Cardiology, University of Alberta, Edmonton, Alta.; University of Ottawa Heart Institute (Paterson), Division of Cardiology, University of Ottawa, Ottawa, Ont.
MD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article extras
Article tools
Persistent myopericarditis after heterologous SARS-CoV-2 mRNA vaccination
Kai Yi Wu, Craig R. Butler, Sheri Koshman, Gavin Y. Oudit, D. Ian Paterson
CMAJ Apr 2023, 195 (16) E584-E587; DOI: 10.1503/cmaj.221510
Jump to section
Related Articles
Cited By...
- No citing articles found.